Analysis of cardiovascular disease prevention indicators among residents with intra-urban migration in Central China
HUANG Tianshu1, TIAN Yuan1, ZHANG Xingyi1, LI Chenhui1, ZHAO Yun1, ZHAO Dongyuan1, CHEN Xianhua1, ZHU Mengyao1, JIAO Guanqi1, GUO Dongmin1, LI Xi1,2, CUI Jianlan2
1. Department of Biological Sample Resources, Central China Sub-center of National Center for Cardiovascular Diseases, Zhengzhou, Henan 450046, China; 2. Chinese Academy of Medical Sciences Fuwai Hospital National Center for Cardiovascular Diseases, Beijing 102308, China
Abstract：Objective To investigate cardiovascular disease (CVD) prevention status among residents with intra-urban migration in Central China, so as to provide insights into targeted prevention and control of CVD. Methods Basic data of residents aged 35 to 75 years who participated in Early Screening and Comprehensive Intervention Project for CVD high-risk populations in Central China from September 2015 to August 2020 were collected. According to birth place, type of registered residence and current residence, residents were divided into four groups: local residents in old urban area, local residents in new urban area, other urban migrants and other rural migrants. The status of CVD primary and secondary prevention, were analysed by using a robust Poisson regression model. Results A total of 76 513 residents were recruited, including 29 420 males (38.45%) and 47 093 females (61.55%), and had a mean age of (56.36±9.84) years. There were 45 087 (58.93%) local residents in old urban area, 23 868 (31.19%) local residents in new urban area, 5 668 (7.41%) other urban migrants and 1 890 (2.47%) other rural migrants. After adjusting for variables such as age, gender and educational level, the results of robust Poisson regression analysis showed that compared with local residents in old urban area, local residents in new urban area had lower compliance rates of non- or moderate-drinking (RR=0.987, 95%CI: 0.975-1.000) and healthy diet (RR=0.535, 95%CI: 0.365-0.782), lower proportion of using aspirin as primary prevention in CVD high-risk population (RR=0.616, 95%CI: 0.511-0.741), lower awareness (RR=0.873, 95%CI: 0.782-0.974) and control rates (RR=0.730, 95%CI: 0.627-0.849) of hypertension; other urban migrants had higher compliance rate of non-smoking (RR=1.045, 95%CI: 1.017-1.075); other rural migrants had lower proportion of using aspirin as primary prevention in CVD high-risk population (RR=0.826, 95%CI: 0.707-0.966). Conclusion The CVD primaryprevention among local residents in new urban area is relatively poor among four groups of residents in Central China, and key interventions are needed.
[1] 马丽媛,吴亚哲,王文,等.《中国心血管病报告2017》要点解读[J].中国心血管杂志,2018,23(1):3-6. [2] 《中国心血管健康与疾病报告2022》编写组.《中国心血管健康与疾病报告2022》要点解读[J].中国心血管杂志,2023,28(4):297-312. [3] 庞林鸿.云南省成年居民心血管病危险因素聚集性特征及发病风险评估[D].昆明:昆明医科大学,2023. [4] FU Y W,LIN W W,YANG Y,et al.Analysis of diverse factors influencing the health status as well as medical and health service utilization in the floating elderly of China[J].BMC Health Serv Res,2021,21(1):1-21. [5] CHEN J.Chronic conditions and receipt of treatment among urbanized rural residents in China[J/OL].BioMed Research Int,2013[2024-04-17].https://doi.org/10.1155/2013/568959. [6] 中国心血管病风险评估和管理指南编写联合委员会.中国心血管病风险评估和管理指南[J].中华预防医学杂志,2019,53(1):13-35. [7] 王椿淇,张行易,李希,等.华北地区23万人健康生活方式与心血管死亡和全因死亡的关系研究[J].中国预防医学杂志,2024,25(2):137-144. [8] 江雨晨,高倩.阿司匹林预防心血管疾病研究进展[J].预防医学,2024,36(4):304-307,313. [9] 中国心血管病预防指南(2017)写作组,中华心血管病杂志编辑委员会.中国心血管病预防指南(2017)[J].中华心血管病杂志,2018,46(1):10-25. [10] LU J P,XUAN S,DOWNING N S,et al.Protocol for the China PEACE(Patient-centered Evaluative Assessment of Cardiac Events)Million Persons Project pilot[J].BMJ Open,2016,6(1):1-14. [11] ARNETT D K,BLUMENTHAL R S,ALBERT M A,et al.2019 ACC/AHA guideline on the primary prevention of cardiovascular disease:a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[J].Circulation,2019,140(11):596-646. [12] WHO CVD Risk Chart Working Group.World Health Organization cardiovascular disease risk charts:revised models to estimate risk in 21 global regions[J].Lancet Glob Health,2019,7(10):1332-1345. [13] YUSUF S,ISLAM S,CHOW C K,et al.Use of secondary prevention drugs for cardiovascular disease in the community in high-income,middle-income,and low-income countries(the PURE Study):a prospective epidemiological survey[J].Lancet,2011,378(9798):1231-1243. [14] LU J P,LU Y,WANG X C,et al.Prevalence,awareness,treatment,and control of hypertension in China:data from 1.7 million adults in a population-based screening study(China PEACE Million Persons Project)[J].Lancet,2017,390(10112):2549-2558. [15] LI X,LU J P,HU S,et al.The primary health-care system in China[J].Lancet,2017,390(10112):2584-2594. [16] COHEN J.A power primer[J].Psychol Bull,1992,112(1):155-159. [17] LÜ J,QI L,YU C Q,et al.Consumption of spicy foods and total and cause specific mortality:population based cohort study[J/OL].BMJ,2015,351[2024-04-17].https://doi.org/10.1136/bmj.h3942. [18] KOKUBO Y.Prevention of hypertension and cardiovascular diseases:a comparison of lifestyle factors in Westerners and East Asians[J].Hypertension,2014,63(4):655-660. [19] ZHU Y G,IOANNIDIS J P,LI H,et al.Understanding and harnessing the health effects of rapid urbanization in China[J].Environ Sci Technol,2011,45(12):5099-5104. [20] LI S S,ZHOU F,LU Y C,et al.Hypertension related knowledge and behaviour associated with awareness,treatment and control of hypertension in a rural hypertensive population:a community based,cross-sectional survey[J].Blood Press,2016,25(5):305-311. [21] 于冬梅,李淑娟,琚腊红,等.2010—2012年中国成年居民高血压知晓率、治疗率和控制率现况[J].卫生研究,2019,48(6):913-918. [22] LI X H,WANG C P,ZHANG G Q,et al.Urbanisation and human health in China:spatial features and a systemic perspective[J].Environ Sci Pollut Res Int,2012,19(5):1375-1384.
